ArticleCurrent oncology (Toronto, Ont.)2024

Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor.

Lucio N Gordan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.